RECIST and iRECIST Comparison in a Cohort of Patients with Advanced NSCLC Treated with Immunotherapy: Preliminary Study

被引：0
|
作者：
Garcia Martinez, F. [1 ]
Fernandez-Velilla Pena, M. [2 ]
Cruz Castellanos, P. [1 ]
De Castro Carpeno, J. [1 ]
Pertejo, A. [1 ]
Torres Sanchez, I. [1 ]
机构：
[1] Hosp Univ La Paz, Radiodiagnost, Madrid, Spain
[2] Hosp Univ La Paz, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Immunotherapy; RECIST; iRECIST;
D O I：
10.1016/j.jtho.2019.08.2152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-30
引用
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [41] Biological and clinical prognostic factors in patients with advanced non-small-cell cancer (NSCLC) treated by erlotinib: Preliminary results of the ERMETIC cohort
    Cadranel, J.
    Beau-Faller, M.
    Mauguen, A.
    Lizard, S.
    Madelaine, J.
    Lansiaux, A.
    Pretet, J.
    Madroszyk, A.
    Chouaid, C.
    Morin, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Predictive and prognostic significance of PIOS (Patras Immunotherapy Score) model in patients with advanced NSCLC treated with nivolumab or pembrolizumab: Results from a validation cohort.
    Dimtrakopoulos, Foteinos-Ioannis D.
    Mountzios, Giannis Socrates
    Christopoulos, Petros
    Papastergiou, Thomas
    Zervas, Eleftherios
    Agelaki, Sofia
    Samantas, Epaminondas
    Athanasiadis, Ilias
    Baka, Sofia
    Syrigos, Kostas N.
    Christopoulou, Athina
    Lianos, Evangelos
    Tsoukalas, Nikolaos
    Perdikouri, Eleni Isidora
    Oikonomopoulos, Georgios
    Kalofonou, Foteini
    Makatsoris, Thomas
    Koutras, Angelos
    Megalooikonomou, Vasileios
    Kalofonos, Haralabos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Evaluation of response to chemotherapy in NSCLC patients: An interdisciplinary comparison using RECIST and WHO criteria
    Grossi, F
    Belvedere, O
    Bazzocchi, M
    Buffoli, A
    Ceschia, T
    Dolcet, F
    Fasola, G
    Mariuzzi, L
    Morelli, A
    Polsinelli, M
    Reccardini, F
    Sacco, C
    Sibau, A
    Talmassons, G
    Zussino, M
    Sobrero, A
    ANNALS OF ONCOLOGY, 2000, 11 : 5 - 5
  • [44] Effect of Gefitinib Combined with Chemotherapy in Patients with Advanced NSCLC: A Retrospective Cohort Study
    Dai, Lili
    Wang, Wei
    Li, Wenli
    Wu, Ya
    Qu, Kaixin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 637 - 644
  • [45] Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy
    Prelaj, Arsela
    Boeri, Mattia
    Robuschi, Alessandro
    Proto, Claudia
    Lo Russo, Giuseppe
    Ferrara, Roberto
    Galli, Giulia
    De Toma, Alessandro
    Brambilla, Marta
    Occhipinti, Mario
    Manglaviti, Sara
    Labianca, Alice
    Beninato, Teresa
    Bini, Marta
    Mensah, Mavis
    Ganzinelli, Monica
    Zilembo, Nicoletta
    De Braud, Filippo
    Sozzi, Gabriella
    Restelli, Marcello
    Pedrocchi, Alessandra
    Garassino, Marina Chiara
    Trovo, Francesco
    CLINICAL CANCER RESEARCH, 2021, 27 (05)
  • [46] Blood cytokine changes in patients with advanced NSCLC receiving immunotherapy
    Schindler, H. L.
    Lusky, F.
    Gaissmaier, L.
    Daniello, L.
    Elshiaty, M.
    Bozorgmehr, F.
    Kuon, J.
    Shah, R.
    Schneider, M.
    Eichhorn, F.
    Baum, P.
    Angeles, A.
    Janke, F.
    Kriegsmann, M.
    Kazdal, D.
    Stenzinger, A.
    Sultmann, H.
    Thomas, M.
    Christopoulos, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S61 - S62
  • [47] Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy
    Kim, Y.
    Kim, C. H.
    Lee, S.
    Lee, H. Y.
    Kim, H. S.
    Kim, K.
    Sun, J.
    Ahn, J. S.
    Ahn, M.
    Park, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [48] A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
    Mazzaschi, G.
    Scandino, R.
    Milanese, G.
    Pavone, C.
    Maurizio, B.
    Silva, M.
    Ledda, R.
    Minari, R.
    Trentini, F.
    Buti, S.
    Bordi, P.
    Leonetti, A.
    Quaini, F.
    Sverzellati, N.
    Romanel, A.
    Tiseo, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1027 - S1027
  • [49] Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
    Boeri, Mattia
    Milione, Massimo
    Proto, Claudia
    Signorelli, Diego
    Lo Russo, Giuseppe
    Galeone, Carlotta
    Verri, Carla
    Mensah, Mavis
    Centonze, Giovanni
    Martinetti, Antonia
    Sottotetti, Elisa
    Pastorino, Ugo
    Garassino, Marina Chiara
    Sozzi, Gabriella
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2166 - 2173
  • [50] Aggressiveness of care in a prospective cohort of patients with advanced NSCLC
    Temel, Jennifer S.
    McCannon, Jessica
    Greer, Joseph A.
    Jackson, Vicki A.
    Ostler, Patricia
    Pirl, William F.
    Lynch, Thomas J.
    Billings, J. Andrew
    CANCER, 2008, 113 (04) : 826 - 833
12345